Rx/Reimbursement Adult Incontinence in Hungary

  • ID: 4517570
  • Report
  • Region: Hungary
  • 15 pages
  • Euromonitor International
1 of 3
During and after the economic crisis, from 2009 until recent years there were tight limits on budgets for healthcare. However, health insurance and reimbursements were not cut back significantly in Hungary, and the spending on subsidies for medical aids continued to increase. Thanks to the continued economic growth, the government started to allocate more of its budget to improve conditions in domestic healthcare services. In the meantime, the spending power of even lower-income segments and pen...

The publisher's Rx/Reimbursement adult incontinence in Hungary report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 3
Rx/Reimbursement Adult Incontinence In Germany

Headlines

Prospects

Incontinence Being A Dreaded Topic Reduces Potential For Rx/Reimbursement Adult Incontinence Products
Insurance Policies To Limit Product Selection And Sales Growth
Growth Potential Limited Further By Prescription Products Being Sold Only Through Pharmacies

Category Data
Table 1 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2012-2017
Table 2 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2012-2017
Table 3 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2017-2022
Table 4 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2017-2022
Executive Summary
Tissue And Hygiene In Germany - A Mature Environment That Still Holds Potential
Success Is In The Detail - Extra Growth Through Premiumisation
The Air Continues To Thin For Leading Brand Manufacturers As Private Label Shares Grow
Tissue And Hygiene Remains In-Store
Demographics And Designs Expected To Lead To Further Growth

Market Indicators
Table 5 Birth Rates 2012-2017
Table 6 Infant Population 2012-2017
Table 7 Female Population By Age 2012-2017
Table 8 Total Population By Age 2012-2017
Table 9 Households 2012-2017
Table 10 Forecast Infant Population 2017-2022
Table 11 Forecast Female Population By Age 2017-2022
Table 12 Forecast Total Population By Age 2017-2022
Table 13 Forecast Households 2017-2022

Market Data
Table 14 Retail Sales Of Tissue And Hygiene By Category: Value 2012-2017
Table 15 Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2012-2017
Table 16 Nbo Company Shares Of Retail Tissue And Hygiene: % Value 2013-2017
Table 17 Lbn Brand Shares Of Retail Tissue And Hygiene: % Value 2014-2017
Table 18 Penetration Of Private Label In Retail Tissue And Hygiene By Category: % Value 2012-2017
Table 19 Distribution Of Retail Tissue And Hygiene By Format: % Value 2012-2017
Table 20 Distribution Of Retail Tissue And Hygiene By Format And Category: % Value 2017
Table 21 Forecast Retail Sales Of Tissue And Hygiene By Category: Value 2017-2022
Table 22 Forecast Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2017-2022
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll